Stockscreener 앱 받기
32.11
4.32%
1.33
시간 외 거래:
32.11
전일 마감가:
$30.78
열려 있는:
$30.78
하루 거래량:
97,760
Relative Volume:
0.53
시가총액:
$402.24M
수익:
-
순이익/손실:
$-51.74M
주가수익비율:
-7.2253
EPS:
-4.4441
순현금흐름:
$-44.57M
1주 성능:
+16.38%
1개월 성능:
-1.17%
6개월 성능:
+203.78%
1년 성능:
+187.98%
1일 변동 폭
$30.45
$32.28
1주일 범위
$26.50
$32.28
52주 변동 폭
$4.90
$35.62
Forte Biosciences Inc Stock (FBRX) Company Profile
명칭
Forte Biosciences Inc
전화
(310) 618-6994
주소
3060 PEGASUS PARK DRIVE, DALLAS, CA
Compare FBRX vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
FBRX
Forte Biosciences Inc
|
32.11 | 385.58M | 0 | -51.74M | -44.57M | -4.4441 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Forte Biosciences Inc Stock (FBRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-25 | 개시 | Evercore ISI | Outperform |
| 2025-08-18 | 개시 | Guggenheim | Buy |
| 2025-01-21 | 개시 | TD Cowen | Buy |
| 2024-04-08 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy |
| 2021-09-20 | 업그레이드 | Chardan Capital Markets | Sell → Buy |
| 2021-09-03 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2021-09-03 | 다운그레이드 | Chardan Capital Markets | Buy → Sell |
| 2021-09-03 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2021-09-03 | 다운그레이드 | Truist | Buy → Hold |
| 2021-05-14 | 개시 | B. Riley Securities | Buy |
| 2021-03-26 | 개시 | Citigroup | Buy |
| 2020-08-28 | 업그레이드 | Chardan Capital Markets | Neutral → Buy |
| 2020-08-25 | 개시 | Truist | Buy |
모두보기
Forte Biosciences Inc 주식(FBRX)의 최신 뉴스
Can Forte Biosciences Inc. maintain its current growth rateDollar Strength & AI Powered Buy/Sell Recommendations - mfd.ru
Institutional Owners May Ignore Forte Biosciences, Inc.'s (NASDAQ:FBRX) Recent US$87m Market Cap Decline as Longer-term Profits Stay in the Green - 富途牛牛
Layoff Watch: Is Forte Biosciences Inc being accumulated by smart moneyJuly 2025 Rallies & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Forte Biosciences, Inc. to Present at Upcoming Investor Meetings - marketscreener.com
Forte Biosciences chief lines up Guggenheim, TD Cowen, Barclays talks - Stock Titan
Forte Biosciences Insider Ups Holding By 30% During Year - simplywall.st
Aug Outlook: Will BEAM stock recover after earningsWeekly Trade Review & Expert Verified Movement Alerts - baoquankhu1.vn
(FBRX) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Investors Purchase Large Volume of Forte Biosciences Call Options (NASDAQ:FBRX) - MarketBeat
Dow Update: Will Forte Biosciences Inc announce a stock splitWeekly Trading Summary & Weekly Momentum Picks - baoquankhu1.vn
Short Interest in Forte Biosciences, Inc. (NASDAQ:FBRX) Expands By 55.5% - MarketBeat
Federated Hermes Inc. Acquires 563,147 Shares of Forte Biosciences, Inc. $FBRX - MarketBeat
Celiac Disease Pipeline 2025: FDA Updates, Therapy - openPR.com
(FBRX) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Celiac Disease Clinical Trial Pipeline Gains Momentum: 25+ - openPR.com
Trend Recap: Can META stock outperform in a bear marketTrade Volume Summary & AI Forecast Swing Trade Picks - baoquankhu1.vn
US Market Recap: What is the earnings history of Jupiter Neurosciences Inc2025 Stock Rankings & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Traders Purchase Large Volume of Forte Biosciences Call Options (NASDAQ:FBRX) - MarketBeat
CD122’s double whammy makes for intriguing target - BioWorld MedTech
Is Forte Biosciences Inc. stock oversold or undervaluedJuly 2025 Sector Moves & Real-Time Volume Triggers - Bollywood Helpline
Is Forte Biosciences Inc a top pick in the sectorWeekly Trade Review & Expert Verified Movement Alerts - baoquankhu1.vn
Support Test: How does INVE compare to its peersQuarterly Portfolio Review & Daily Growth Stock Tips - baoquankhu1.vn
Layoff Watch: Is ERAS stock undervalued right nowMarket Performance Summary & Safe Entry Momentum Stock Tips - baoquankhu1.vn
Value Recap: Does Forte Biosciences Inc have pricing powerPortfolio Gains Report & Daily Growth Stock Tips - baoquankhu1.vn
Trade Recap: Is Forte Biosciences Inc. stock a hidden gemWeekly Gains Report & Low Risk Profit Maximizing Plans - baoquankhu1.vn
Forte Biosciences, Inc. (NASDAQ:FBRX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Forte Biosciences, Inc. (NASDAQ:FBRX) Short Interest Up 267.7% in December - MarketBeat
Delaware court rules in D&O dispute - businessinsurance.com
Delaware court expands D&O insurer liability through meaningful linkage ruling - Insurance Business
A activityJuly 2025 Analyst Calls & Weekly Top Gainers Trade List - ulpravda.ru
Will Forte Biosciences Inc. stock outperform international peersLayoff News & High Return Stock Watch Alerts - Улправда
Biopharma Co. Secures D&O Coverage For Shareholder Suit - Law360
Why Forte Biosciences Inc. stock is rated strong buyWeekly Investment Summary & Expert Curated Trade Ideas - Улправда
Will Forte Biosciences Inc. stock reach all time highs in 2025CPI Data & Expert Curated Trade Setups - Улправда
How supply shortages influence HCI stockJuly 2025 Review & Community Driven Trade Alerts - Улправда
What margin trends mean for VNET Group Inc. Depositary Receipt stockTrade Risk Report & Long-Term Safe Investment Ideas - Улправда
What valuation multiples suggest for HAYW stockWeekly Risk Summary & Consistent Growth Equity Picks - Улправда
ulpravda ru > 2026> What insider trading reveals about COLL stockChart Signals & Low Drawdown Momentum Ideas - ulpravda.ru
Will Quad Graphics Inc. stock return to pre crisis levels2025 Key Highlights & Expert Approved Trade Ideas - ulpravda.ru
Forte Biosciences Sees Unusually High Options Volume (NASDAQ:FBRX) - Defense World
(FBRX) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Will Avax Apparels and Ornaments Limited Bounce From 52 Week LowPortfolio Risk Assessment & Interactive Learning for Better Returns - earlytimes.in
Will Sahasra Electronic Solutions Limited Recover After Recent DeclineSupport and Resistance Levels & Access Free Risk Analysis Before You Invest - earlytimes.in
What drives Forte Biosciences Inc stock priceMean Reversion Trades & Receive Monthly Expert Trading Blueprints - earlytimes.in
TD Cowen Initiates Coverage of Forte Biosciences (FBRX) with Buy Recommendation - MSN
Chief Financial Officer of Forte Biosciences Picks Up 30% More Stock - Yahoo Finance
Institutional investors may adopt severe steps after Forte Biosciences, Inc.'s (NASDAQ:FBRX) latest 15% drop adds to a year losses - simplywall.st
Insider Buying: Antony Riley Acquires Shares of Forte Biosciences Inc (FBRX) - GuruFocus
Trading Bots Trigger Alerts on Shri Venkatesh Refineries Limited ActivityHigh Frequency Trading Trends & Fast Profit Trading Ideas - bollywoodhelpline.com
Indo Tech Transformers Limited (INDOTECH) Stock RalliesStock Liquidity Analysis & Discover Stocks Experts Are Watching - bollywoodhelpline.com
Dr. Lal PathLabs Limited (LALPATHLAB) Expands into New MarketRisk-Reward Ratio Analysis & Fast Profit Capital Growth - bollywoodhelpline.com
Forte Biosciences Inc (FBRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Forte Biosciences Inc 주식 (FBRX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Riley Antony A | CHIEF FINANCIAL OFFICER |
Jan 01 '26 |
Option Exercise |
0.00 |
375 |
0 |
41,895 |
| Riley Antony A | CHIEF FINANCIAL OFFICER |
Dec 30 '25 |
Buy |
26.33 |
9,680 |
254,833 |
41,520 |
| Riley Antony A | CHIEF FINANCIAL OFFICER |
Oct 01 '25 |
Option Exercise |
0.00 |
375 |
0 |
31,974 |
| Wagner Paul A. | SEE REMARKS |
Oct 01 '25 |
Option Exercise |
0.00 |
1,250 |
0 |
82,190 |
| Riley Antony A | CHIEF FINANCIAL OFFICER |
Jul 01 '25 |
Option Exercise |
0.00 |
375 |
0 |
31,733 |
| Wagner Paul A. | SEE REMARKS |
Jul 01 '25 |
Option Exercise |
0.00 |
1,250 |
0 |
81,038 |
| Riley Antony A | CHIEF FINANCIAL OFFICER |
Apr 01 '25 |
Option Exercise |
0.00 |
375 |
0 |
31,372 |
| Wagner Paul A. | SEE REMARKS |
Apr 01 '25 |
Option Exercise |
0.00 |
1,250 |
0 |
79,806 |
1.12%
0.87%
자본화:
|
볼륨(24시간):